ArriVent BioPharma Statistics

Total Valuation

AVBP has a market cap or net worth of $644.61 million. The enterprise value is $425.92 million.

Market Cap	644.61M
Enterprise Value	425.92M

Important Dates

The last earnings date was Monday, March 3, 2025, before market open.

Earnings Date	Mar 3, 2025
Ex-Dividend Date	n/a

Share Statistics

AVBP has 34.02 million shares outstanding. The number of shares has increased by 1,369.88% in one year.

Current Share Class	34.02M
Shares Outstanding	34.02M
Shares Change (YoY)	+1,369.88%
Shares Change (QoQ)	+0.40%
Owned by Insiders (%)	2.62%
Owned by Institutions (%)	54.39%
Float	15.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.48
P/TBV Ratio	2.50
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.14, with a Debt / Equity ratio of 0.00.

Current Ratio	13.14
Quick Ratio	12.70
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -39.36% and return on invested capital (ROIC) is -28.79%.

Return on Equity (ROE)	-39.36%
Return on Assets (ROA)	-26.91%
Return on Invested Capital (ROIC)	-28.79%
Return on Capital Employed (ROCE)	-36.60%
Revenue Per Employee	n/a
Profits Per Employee	-$1.55M
Employee Count	52
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.28% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+5.28%
50-Day Moving Average	24.30
200-Day Moving Average	24.87
Relative Strength Index (RSI)	31.12
Average Volume (20 Days)	191,753

Short Selling Information

The latest short interest is 3.69 million, so 10.84% of the outstanding shares have been sold short.

Short Interest	3.69M
Short Previous Month	3.73M
Short % of Shares Out	10.84%
Short % of Float	23.28%
Short Ratio (days to cover)	19.59

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-94.31M
Pretax Income	n/a
Net Income	-80.49M
EBITDA	n/a
EBIT	-94.31M
Earnings Per Share (EPS)	-$2.56

Full Income Statement

Balance Sheet

The company has $218.86 million in cash and $176,000 in debt, giving a net cash position of $218.69 million or $6.43 per share.

Cash & Cash Equivalents	218.86M
Total Debt	176,000
Net Cash	218.69M
Net Cash Per Share	$6.43
Equity (Book Value)	257.65M
Book Value Per Share	7.64
Working Capital	209.71M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-70.21M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AVBP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,369.88%
Shareholder Yield	n/a
Earnings Yield	-12.49%
FCF Yield	n/a

Analyst Forecast

The average price target for AVBP is $39.00, which is 105.81% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$39.00
Price Target Difference	105.81%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	10.28%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1